Koers Carl Zeiss Meditec AG Berne S.E.
Aandelen
AFX
DE0005313704
Geavanceerde medische apparatuur & technologie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
104,7 CHF | -10,65% | -10,65% | +12,25% |
16/05 | CARL ZEISS MEDITEC AG : UBS herhaalt koopadvies | ZD |
10/05 | CARL ZEISS MEDITEC AG : Hauck & Aufhauser handhaaft koopadvies | ZD |
Omzet 2024 * | 2,24 mld. 2,43 mld. 2,21 mld. | Omzet 2025 * | 2,52 mld. 2,74 mld. 2,49 mld. | Marktkapitalisatie | 8,52 mld. 9,26 mld. 8,42 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 254 mln. 276 mln. 251 mln. | Nettowinst (verlies) 2025 * | 314 mln. 341 mln. 310 mln. | EV/omzet 2024 * | 3,99 x |
Nettoschuld 2024 * | 396 mln. 430 mln. 391 mln. | Nettoschuld 2025 * | 488 mln. 530 mln. 482 mln. | EV/omzet 2025 * | 3,57 x |
K/w-verhouding 2024 * |
33,3
x | K/w-verhouding 2025 * |
26,8
x | Werknemers | - |
Dividendrendement 2024 * |
1,11% | Dividendrendement 2025 * |
1,26% | Vrij verhandelbaar | 40,86% |
Recentste transcriptie over Carl Zeiss Meditec AG
1 dag | -10,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Markus Weber
CEO | Chief Executive Officer | 51 | 31-12-21 |
Director of Finance/CFO | 59 | 01-10-18 | |
Christian Müller
BRD | Director/Board Member | 57 | 15-12-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Kaschke
BRD | Director/Board Member | 66 | 01-01-02 |
Christian Müller
BRD | Director/Board Member | 57 | 15-12-09 |
Peter Kameritsch
BRD | Director/Board Member | 55 | 27-05-21 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,15% | 227 mld. | |
+14,90% | 197 mld. | |
+18,22% | 141 mld. | |
+29,15% | 110 mld. | |
+0,53% | 64,15 mld. | |
+16,92% | 53,72 mld. | |
+6,33% | 51,75 mld. | |
+10,93% | 45,2 mld. | |
+5,87% | 37,37 mld. |